Skip to content
GenoLensGenoLens

NOG

Chr 17q22

noggin

MANE:
ENST00000332822.6

Annotations refreshed 10 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • DDG2P

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Fetal anomalies

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Limb disorders

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Skeletal dysplasia

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Primary ovarian insufficiency

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Intellectual disability

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Rare syndromic craniosynostosis or isolated multisuture synostosis

  • VACTERL-like phenotypes

Disease associations (Open Targets)

  • proximal symphalangism 1A

    0.78
  • brachydactyly type B2

    0.77
  • multiple synostoses syndrome 1

    0.75
  • tarsal-carpal coalition syndrome

    0.75
  • stapes ankylosis with broad thumbs and toes

    0.70
  • multiple synostoses syndrome

    0.56
  • proximal symphalangism

    0.56
  • hereditary disease

    0.49
  • NOG-related symphalangism spectrum disorder

    0.46
  • Progressive visual loss

    0.32

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Noggin

Inhibitor of bone morphogenetic proteins (BMP) signaling which is required for growth and patterning of the neural tube and somite. Essential for cartilage morphogenesis and joint formation. Inhibits chondrocyte differentiation through its interaction with GDF5 and, probably, GDF6 (PubMed:21976273, PubMed:26643732)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.